[1]
B. Tatar and Şükran Köse, “Tenofovir plus entecavir combination therapy for chronic hepatitis B with nucleos(t)ide analogue failure”, Eur Res J, vol. 6, no. 4, pp. 270–275, Jul. 2020, doi: 10.18621/eurj.645852.